News

ZEV SCHERL NAMED AS HONORARY CHAIR OF EARLY

STAGE EAST’S BIO•LIFE •TECH CONFERENCE

Over 200 Entrepreneurs and Investors Expected to Attend

King of Prussia, PA – October 16, 2006– NewSpring Capital is pleased to announce that Zev Scherl, General Partner of NewSpring Capital, has been named as the Honorary Chair of Early Stage East’s Bio•Life•Tech Conference. This year’s event will be held December 4th in Princeton, NJ. “We are thrilled to have Zev Scherl and NewSpring Capital involved in Bio·Life·Tech this year,” said Amy Aiq, Director of Early Stage East.

“Bio•Life•Tech is a quality event,” said Scherl. “NewSpring Capital has invested in Bio•Life•Tech 2005 ‘alums’, and we are looking forward to working with the next generation of Bio•Life•Tech CEOs and companies.”

Bio•Life•Tech focuses on early stage companies involved in life sciences, biotechnology, pharmaceuticals, medical instrumentation, and the related emerging technologies. The conference brings together more than 200 entrepreneurs, CEOs, investors and venture capitalists to one of the country’s most productive areas for life science innovation and investment.

About Zev Scherl

Mr. Scherl is a General Partner of NewSpring Healthcare (“CHV”) and NewSpring Capital, with significant experience in principal investing, corporate management and finance, focused exclusively in the life sciences and healthcare industries. Prior to CHV, Zev worked with Pequot Ventures, which manages venture funds in excess of $1 billion, within Pequot Capital, which manages approximately $8 billion. With Pequot Ventures, he originated and successfully executed investments in emerging life sciences and healthcare companies, whose technologies include (but are not limited to) computational genomics, diabetes and orthopedics, and served on many corporate boards. Mr. Scherl is currently a board member of AppTec Laboratory Services, Inc., Scandius BioMedical, Inc., Nitric BioTherapeutics, EKR Therapeutics, Inc., and Immune Control, Inc. Mr. Scherl received a BA with honors in economics from Duke University and an MBA from Harvard Business School.

About NewSpring Capital

NewSpring Capital, based in King of Prussia, PA, manages a family of private equity funds which provide growth equity and mezzanine debt financing to growth and expansion stage companies with a focus on business services, healthcare, life sciences, specialty manufacturing and technology. NewSpring Capital focuses primarily on businesses in the Mid-Atlantic Region and invests between $3-$7.5 million per transaction in round sizes up to $30 million.

###